as on January 12, 2026 at 9:15 am IST
52 Week's Low
52 Week's High
16.83%
Downside
30.50%
Upside
as on January 12, 2026 at 9:15 am IST
Market Cap
₹69.25 Cr
Return on Equity (ROE)
2.75
PE Ratio (TTM)
19.71
Return on capital employed (ROCE)
3.84
Industry PE ratio
47.81
Beta (LTM)
1
P/B Ratio
1.28
Dividend Yield
0PEG Ratio
9.74
Quarterly Earnings Growth YOY
392.31
EPS (TTM)
1.68
Sector
Chemicals
Book Value
41.26
Technical Analysis
Bearish
View Technical Analysis
as on January 12, 2026 at 9:15 am IST
Eiko Lifesciences in the last 5 years
Lowest (-109.77x)
July 11, 2024
Today (19.71x)
January 9, 2026
Industry (47.81x)
January 9, 2026
Highest (131.43x)
October 11, 2024
Today’s Price to Earnings Ratio: 19.71x
Compare market cap, revenue, PE, and other key metrics of Eiko Lifesciences with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 69.25 | 8.27% | 0.52 | 2 | 37 | |
| NA | 82.02 | -4.25% | 0.00 | 4 | 56 | |
| BUY | 3,772.45 | -0.54% | 0.55 | 158 | 1,397 | |
| NA | 3,513.37 | 7.76% | 0.57 | -66 | 4,072 | |
| NA | 926.37 | 3.35% | 0.00 | 21 | 537 |
Get share price movements and forecasts by analysts on Eiko Lifesciences.
Source: S&P Global Market Intelligence
Search interest for Eiko Lifesciences Ltd Stock has decreased by -46% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Eiko Lifesciences.
Eiko Lifesciences Ltd’s net profit jumped 285.71% since last year same period to ₹1.08Cr in the Q2 2025-2026. On a quarterly growth basis, Eiko Lifesciences Ltd has generated 18.68% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2017, Eiko Lifesciences Ltd has declared dividend of ₹0.25 per share on 05 Apr 2017 - translating a dividend yield of 0.49%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Promoter Holding Up
![]()
Promoters have increased holdings from 37.11% to 37.17% in Sep 2025 quarter
Against Peers
![]()
In the last 1 year, SRF Ltd has given 16.2% return, outperforming this stock by 24.7%
Against Peers
![]()
In the last 3 years, Himadri Speciality Chemical Ltd has given 392.8% return, outperforming this stock by 407.1%
Retail Holding Down
![]()
Retail Investor have decreased holdings from 62.89% to 62.83% in Sep 2025 quarter
Price Dip
![]()
In the last 3 years, Eiko Lifescience stock has moved down by -14.2%
| Organisation | Eiko Lifesciences Ltd |
| Industry | Chemicals |
| CEO | Laxmikant Kabra |
| E-voting on shares | Click here to vote |
Eiko Lifesciences share price today stands at ₹50.5 as on . Eiko Lifesciences share today touched a day high of ₹50.5 and a low of ₹50.5.
Eiko Lifesciences touched a 52 week high of ₹65.9 and a 52 week low of ₹42. Eiko Lifesciences share price today i.e. is trending at ₹50.5, which is -23.37% down from its 52 week high and 20.24% up from its 52 week low.
Eiko Lifesciences market capitalisation is ₹69.25 Cr as on .
To buy Eiko Lifesciences shares, you need to follow these steps:
Eiko Lifesciences trading volume is 37.00 as on . This means that 37.00 shares of Eiko Lifesciences were bought and sold on the stock market during today's trading session.